HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kentarou Kudou Selected Research

4,7,10,13,16,19-docosahexaenoic acid ethyl ester

11/2013Long-term safety and efficacy of TAK-085 in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized long-term (ORL) study.
5/2013Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized double-blind (ORD) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kentarou Kudou Research Topics

Disease

5Menorrhagia
10/2021 - 01/2019
3Leiomyoma (Uterine Fibroids)
10/2021 - 01/2019
3Pain (Aches)
01/2021 - 11/2019
3Metrorrhagia (Spotting)
01/2021 - 11/2019
3Hypertriglyceridemia
12/2015 - 05/2013
2Pelvic Pain
01/2021 - 01/2021
2Endometriosis
01/2021 - 01/2021
1Duodenal Ulcer (Curling's Ulcer)
07/2022
1Gastroparesis
01/2022
1Menstruation Disturbances
01/2021
1Hyperhidrosis
11/2019
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2019
1Myoma
01/2019
1Hemorrhage
01/2019
1Heartburn (Pyrosis)
04/2018
1Esophagitis
04/2018
1Prostatic Neoplasms (Prostate Cancer)
12/2015
1Cardiovascular Diseases (Cardiovascular Disease)
05/2013
1Dyslipidemias (Dyslipidemia)
05/2013

Drug/Important Bio-Agent (IBA)

5relugolixIBA
10/2021 - 01/2019
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2021 - 01/2019
4LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
10/2021 - 11/2019
4Leuprolide (Lupron)FDA LinkGeneric
01/2021 - 12/2015
3TAK-085IBA
12/2015 - 05/2013
2Lansoprazole (Prevacid)FDA LinkGeneric
07/2022 - 04/2018
2Pharmaceutical PreparationsIBA
07/2022 - 11/2019
21- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
07/2022 - 04/2018
2Acetates (Acetic Acid Esters)FDA Link
01/2019 - 12/2015
2Eicosapentaenoic AcidIBA
12/2015 - 05/2013
24,7,10,13,16,19-docosahexaenoic acid ethyl esterIBA
11/2013 - 05/2013
2eicosapentaenoic acid ethyl esterIBA
11/2013 - 05/2013
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
11/2013 - 05/2013
2Triglycerides (Triacylglycerol)IBA
11/2013 - 05/2013
1trazpirobenIBA
01/2022
1Dopamine (Intropin)FDA LinkGeneric
01/2022
1Hemoglobins (Hemoglobin)IBA
01/2019
1AcidsIBA
04/2018
1LDL CholesterolIBA
12/2015
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2015
1EstersIBA
12/2015
1ApolipoproteinsIBA
12/2015
1oxidized low density lipoproteinIBA
12/2015
1polyacrylamideIBA
12/2015
1LipidsIBA
11/2013

Therapy/Procedure

2Therapeutics
01/2022 - 04/2018
1Oral Administration
01/2021
1Injections
01/2019
1Aftercare (After-Treatment)
01/2019